Euroopa Liit - eesti - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Euroopa Liit - eesti - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic hape, sitagliptin fosfaat, monohüdraat - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - steglujan on näidustatud täiskasvanutel vanuses 18 aastat ja vanemad, tüüp 2 diabeet lisandina toitumise ja treeningu parandamiseks glycaemic kontroll:kui metformiin ja/või sulphonylurea (su) ja üks monocomponents kohta steglujan ei taga piisavat kontrolli glycaemic. patsientidel, juba ravitakse kombinatsioon ertugliflozin ja sitagliptin kui eraldi tabletid.

Eesti - eesti - Ravimiamet

orion pharma - vitamiinide kombinatsioonid - suukaudsed tilgad, lahus - 20ml 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - kassid - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinaarravim on üksnes märgitud, kui kõik kolm gruppi on suunatud samal ajal.

Euroopa Liit - eesti - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 ja 5.